title: The effect of preservative-free HP-Guar on dry eye after phacoemulsification: a flow cytometric study.
authors.affiliation: Department of Ophthalmology, Hospital Clínico San Carlos, Madrid, Spain.
authors.forename: M A
authors.initials: MA
authors.lastname: Sánchez
authors.forename: P
authors.initials: P
authors.lastname: Arriola-Villalobos
authors.forename: P
authors.initials: P
authors.lastname: Torralbo-Jiménez
authors.forename: N
authors.initials: N
authors.lastname: Girón
authors.forename: B
authors.initials: B
authors.lastname: de la Heras
authors.forename: R
authors.initials: R
authors.lastname: Herrero Vanrell
authors.forename: A
authors.initials: A
authors.lastname: Alvarez-Barrientos
authors.forename: J M
authors.initials: JM
authors.lastname: Benítez-del-Castillo
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015703:Antigens, CD / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D003228:Conjunctiva / Q000187:drug effects / Q000378:metabolism; D003315:Cornea / Q000187:drug effects; D003907:Dexamethasone / Q000627:therapeutic use; D015352:Dry Eye Syndromes / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D005260:Female; D005434:Flow Cytometry; D006684:HLA-DR Antigens / Q000378:metabolism; D006801:Humans; D008297:Male; D009883:Ophthalmic Solutions / Q000494:pharmacology*; D018918:Phacoemulsification / Q000009:adverse effects*; D011134:Polysaccharides / Q000494:pharmacology*; D011446:Prospective Studies; D013666:Tears / Q000502:physiology; D014031:Tobramycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D015703:Antigens, CD; D015415:Biomarkers; D006684:HLA-DR Antigens; D009883:Ophthalmic Solutions; D011134:Polysaccharides; C519976:hydroxypropyl guar; D003907:Dexamethasone; D014031:Tobramycin